PAR-21-045 - Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 4
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Accelerating Research in Understudied Skin Types | NOT-AR-24-009 | NIAMS | Jul 31, 2023 | Jul 17, 2026 | R21, R01, R34 |
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening | NOT-OD-22-179 | ODP NIA NIAAA NIAMS NICHD NIDA NIDCD NIDCR NIMH NIMHD NINDS NINR ODS ORWH | Jul 14, 2022 | May 8, 2025 | R21, R01, R61/R33, UG3/UH3, R34, U01 |
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening | NOT-OD-22-107 | ODP NIA NIAAA NIAMS NICHD NIDA NIDCD NIDCR NIMH NIMHD NINDS NINR ODS ORWH | May 12, 2022 | May 8, 2025 | 333, R01, R34, R21, R61/R33, U01, UG3/UH3 |
Notice of Special Interest (NOSI): Promoting Pain Research Within the NIAMS Mission Areas | NOT-AR-22-007 | NIAMS | Sep 23, 2021 | Jan 10, 2023 | R01, R21, R15, R33, R13, R34, K99/R00, K24, K01, K25, K23, K08, 332 |